Table 2.
MYDICAR Infusion (mL) |
Nitroglycerin before MYDICAR |
||||
---|---|---|---|---|---|
Cohort/Patient Identification | LCA | RCA | LCA IC (μg) |
RCA IC (μg) |
Other |
Cohort 1/Pt# 1 | 30 | 30 | 0 | 150 | 0 |
Cohort 1/Pt# 2 | 60 | 0 | 0 | 0 | 0 |
Cohort 1/Pt# 3 | 40 | 20 | 0 | 0 | 20 μg/min IV for total of 2118 μg |
Cohort 2/Pt# 1 | 40 | 19 | 0 | 0 | 20 μg/min IV for total of 691.3 μg + 0.4 mg PO |
Cohort 2/Pt# 2 | 59 | 0 | 0 | 0 | 0 |
Cohort 2/Pt# 3 | 38 | 18 | 0 | 0 | 0 |
Cohort 3/Pt# 1 | 40 | 20 | 0 | 150 | 0 |
Cohort 3/Pt# 2 | 40 | 21 | 150 | 150 | 0 |
Cohort 3/Pt# 3 | 61 | 0 | 150 | 0 | 0 |
LCA, left coronary artery; RCA, right coronary artery; IC, intracoronary.